Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model

Virus Research

Volumn 178, Issue 2, 2013, Pages 411-422

  Lee, Yu Hsiang ^a   Lai, Chai Lin ^a   Hsieh, Shih Hung ^a   Shieh, Chi Chang ^b   Huang, Li Min ^c   Wu Hsieh, Betty A ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Influenza A virus; Lung pathology; MMP 9; Oxidative stress

Indexed keywords

CD11B ANTIGEN; GELATINASE A; GELATINASE B; GRANULOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROGEN DERIVATIVE; OXYGEN; PHOSPHOLIPID; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOLOGY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LIPID OXIDATION; LUNG INFECTION; LUNG LAVAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; VIRUS INDUCTION; VIRUS INFECTION; VIRUS VIRULENCE; ZYMOGRAPHY;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

INFLUENZA A VIRUS; LUNG PATHOLOGY; MMP-9; OXIDATIVE STRESS;

ANIMALS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; LUNG; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84888204752     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.09.011     Document Type: Article

References (35)

1. Adachi M., Matsukura S., Tokunaga H., Kokubu F. Expression of cytokines on human bronchial epithelial cells induced by influenza virus A. Int. Arch. Allergy Immunol. 1997, 113(1-3):307-311.
2. Atkinson J.J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 2003, 28(1):12-24.
3. Bradley L.M., Douglass M.F., Chatterjee D., Akira S., Baaten B.J. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog. 2012, 8(4):e1002641.
4. Bussfeld D., Kaufmann A., Meyer R.G., Gemsa D., Sprenger H. Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immunol. 1998, 186(1):1-7.
5. CDC 2009 H1N1: Overview of a Pandemic 2010, 2012. Centers for Disease Control and Prevention, GA, USA.
6. Cero F.T., Hillestad V., Loberg E.M., Christensen G., Larsen K.O., Skjonsberg O.H. IL-18 and IL-12 synergy induces matrix degrading enzymes in the lung. Exp. Lung Res. 2012, 38(8):406-419.
7. Chang M.K., Bergmark C., Laurila A., Horkko S., Han K.H., Friedman P., Dennis E.A., Witztum J.L. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. PNAS 1999, 96(11):6353-6358.
8. Corbel M., Boichot E., Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz. J. Med. Biol. Res. 2000, 33(7):749-754.
9. Finkelman B.S., Viboud C., Koelle K., Ferrari M.J., Bharti N., Grenfell B.T. Global patterns in seasonal activity of influenza A/H3N2 A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One 2007, 2(12):e1296.
10. Gillotte-Taylor K., Boullier A., Witztum J.L., Steinberg D., Quehenberger O. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 2001, 42(9):1474-1482.
11. Henning Birkedal-Hansen S.Y., Windsor J., Pollard A.H., Lyons G., Stetler-Stevenson W., Birkedal-Hansen B. Gelatin/Casein Zymography, Current Protocols in Cell Biology 2008, John Wiley & Sons Inc., Hoboken, NJ, 10.08. 09-11.
12. Hsieh Y.C., Wu T.Z., Liu D.P., Shao P.L., Chang L.Y., Lu C.Y., Lee C.Y., Huang F.Y., Huang L.M. Influenza pandemics: past, present and future. J. Formos. Med. Assoc. 2006, 105(1):1-6.
13. Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y.H., Wang H., Liu H., Sun Y., Pasparakis M., Kopf M., Mech C., Bavari S., Peiris J.S., Slutsky A.S., Akira S., Hultqvist M., Holmdahl R., Nicholls J., Jiang C., Binder C.J., Penninger J.M. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133(2):235-249.
14. Julkunen I., Sareneva T., Pirhonen J., Ronni T., Melen K., Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 2001, 12(2-3):171-180.
15. Kaji M., Watanabe A., Aizawa H. Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology 2003, 8(2):231-233.
16. Lemaitre M., Carrat F., Rey G., Miller M., Simonsen L., Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One 2012, 7(9):e45051.
17. Liu Y., Mei J., Gonzales L., Yang G., Dai N., Wang P., Zhang P., Favara M., Malcolm K.C., Guttentag S., Worthen G.S. IL-17A and TNF-alpha exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J. Immunol. 2011, 186(5):3197-3205.
18. Mei J., Liu Y., Dai N., Favara M., Greene T., Jeyaseelan S., Poncz M., Lee J.S., Worthen G.S. CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 2010, 33(1):106-117.
19. Ng H.H., Narasaraju T., Phoon M.C., Sim M.K., Seet J.E., Chow V.T. Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases. Exp. Mol. Pathol. 2012, 92(3):287-295.
20. Perrone L.A., Plowden J.K., Garcia-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008, 4(8):e1000115.
21. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J. Clin. Invest. 1996, 98(11):2572-2579.
22. Ramirez M.I., Millien G., Hinds A., Cao Y., Seldin D.C., Williams M.C. T1 alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 2003, 256(1):61-72.
23. Richter C., Juan M.H., Will J., Brandes R.P., Kalinke U., Akira S., Pfeilschifter J.M., Hultqvist M., Holmdahl R., Radeke H.H. Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells. J. Immunol. 2009, 182(7):4183-4191.
24. Ricou B., Nicod L., Lacraz S., Welgus H.G., Suter P.M., Dayer J.M. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1996, 154(2 Pt 1):346-352.
25. Salomon R., Webster R.G. The influenza virus enigma. Cell 2009, 136(3):402-410.
26. Slepushkin V.A., Staber P.D., Wang G., McCray P.B., Davidson B.L. Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains. Mol. Ther. 2001, 3(3):395-402.
27. Vanderbilt J.N., Allen L., Gonzalez R.F., Tigue Z., Edmondson J., Ansaldi D., Gillespie A.M., Dobbs L.G. Directed expression of transgenes to alveolar type I cells in the mouse. Am. J. Respir. Cell Mol. Biol. 2008, 39(3):253-262.
28. Vermeer P.D., Denker J., Estin M., Moninger T.O., Keshavjee S., Karp P., Kline J.N., Zabner J. MMP9 modulates tight junction integrity and cell viability in human airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296(5):L751-L762.
29. Vlahos R., Stambas J., Bozinovski S., Broughton B.R., Drummond G.R., Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 2011, 7(2):e1001271.
30. Wang S., Le T.Q., Kurihara N., Chida J., Cisse Y., Yano M., Kido H. Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J. Infect. Dis. 2010, 202(7):991-1001.
31. Wang S., Quang Le T., Chida J., Cisse Y., Yano M., Kido H. Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection. J. Med. Invest. 2010, 57(1-2):26-34.
32. Wu W., Booth J.L., Duggan E.S., Wu S., Patel K.B., Coggeshall K.M., Metcalf J.P. Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology 2010, 396(2):178-188.
33. Yadav A., Saini V., Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin. Chim. Acta 2010, 411(21-22):1570-1579.
34. Yeo S.J., Kim S.J., Kim J.H., Lee H.J., Kook Y.H. Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells. Arch. Virol. 1999, 144(7):1361-1370.
35. Yoo S.H., Jung K.C., Kim J.H., Sung S.W., Chung J.H., Shim Y.S., Lee S.D., Chung D.H. Expression patterns of markers for type II pneumocytes in pulmonary sclerosing hemangiomas and fetal lung tissues. Arch. Pathol. Lab. Med. 2005, 129(7):915-919.